- Global Pharma News & Resources

Press Releases - 2019-12-20

Date Title Company
20-Dec-2019 EQT to Sell Clinical Innovations EQT
20-Dec-2019 Johnson & Johnson Acquires TARIS Biomedical with Focus on Transforming the Treatment of Bladder Cancer Johnson & Johnson
20-Dec-2019 e5 Pharma Launches Generic Form of Diazoxide; Approved by FDA e5 Pharma
20-Dec-2019 VERO Biotech Receives US FDA Approval of GENOSYL® for the Delivery of Inhaled Nitric Oxide VERO Biotech LLC
20-Dec-2019 FDA, DEA seize 44 websites advertising sale of illicit THC vaping cartridges to US consumers as part of Operation Vapor Lock U.S. Food and Drug Administration
20-Dec-2019 On Eve of New Decade, EpiVax Re-Pledges Commitment to Improving Health Everywhere EpiVax, Inc.
20-Dec-2019 Biofrontera AG: Extraordinary General Meeting of Biofrontera AG: Biofrontera Management Board supported by large majority Biofrontera AG
20-Dec-2019 Enterprise Flash Storage Market Overview with Demographic Data and Industry Growth Trends 2028 MARKITWIRED
20-Dec-2019 Incident And Deviation Management Solution Market – Global Share, Trend, Segmentation and Forecast up to 2028 MARKITWIRED
20-Dec-2019 Marketing Transcription Market: Effect and Growth Factors Research and Projection 2018-2028 MARKITWIRED
20-Dec-2019 Product Cost Management Market Opportunities, Demands and Growth Revenue by 2028 | Future Market Insights Report MARKITWIRED
20-Dec-2019 Brazing Consumables Market Share, Trends and Forecast by Region to 2028 | FMI Detail Report MARKITWIRED
20-Dec-2019 Hydropower Lubricants Market Current Trends and Business Opportunities forecast to 2028 MARKITWIRED
20-Dec-2019 Bavarian Nordic Announces the Sale of Priority Review Voucher Bavarian Nordic
20-Dec-2019 Patent Approved in Japan for Isofol's Drug Candidate Arfolitixorin Isofol Medical
20-Dec-2019 AbbVie Inc. - Rule 2.10 Announcement - Relevant Securities in Issue AbbVie
20-Dec-2019 Sartorius and the German Research Center for Artificial Intelligence Launch Joint Research Laboratory Sartorius
20-Dec-2019 Aglaia Oncology Funds and Sinzer - Grant Thornton Launch Dedicated Life Sciences Impact Measuring and Reporting Suite Aglaia Oncology Funds
20-Dec-2019 RINVOQ® ▼(upadacitinib) Granted EU Marketing Authorisation for the Treatment of Eligible Adults with Moderate to Severe Active Rheumatoid Arthritis AbbVie